GF Fund Management
ORKA icon

GF Fund Management’s Oruka Therapeutics ORKA Stock Holding History

GF Fund Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$108K Buy
1,297
+105
+9% +$9.9K ﹤0.01% 329
2026
Q2 		$113K Buy
1,192
+105
+10% +$7K ﹤0.01% 321
2026
Q1 		$53.3K Buy
1,087
+137
+14% +$4.76K ﹤0.01% 391
2025
Q4 		$28.8K Buy
950
+144
+18% +$4.01K ﹤0.01% 467
2025
Q3 		$15.5K Sell
806
-90
-10% -$1.33K ﹤0.01% 521
2025
Q2 		$10K Hold
896
– – ﹤0.01% 569
2025
Q1 		$9.19K Buy
896
+161
+22% +$2.01K ﹤0.01% 576
2024
Q4 		$14.3K Buy
+735
New +$17.9K ﹤0.01% 504

Other funds holding ORKA

Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
First Affirmative Financial Network
First Affirmative Financial Network Colorado Springs, Colorado $456M AUM
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Stone House Investment Management
Stone House Investment Management Tunkhannock, Pennsylvania $768M AUM 12.07% 1-Year Est. Return

GF Fund Management's ORKA Position: Q3 2026 in Review

GF Fund Management increased its Oruka Therapeutics (ORKA) stake by 8.8% in Q3 2026, buying an estimated $9.9K and bringing the position to 1,297 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #329.

GF Fund Management first reported a position in ORKA in Q4 2024 and has held it in 8 quarters since. The position peaked at $113K in Q2 2026. 29 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • GF Fund Management held 1,297 shares of Oruka Therapeutics worth $108K as of Q3 2026.
  • GF Fund Management bought 105 Oruka Therapeutics shares in Q3 2026, an estimated $9.9K.
  • Oruka Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #329 holding.
  • GF Fund Management first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • GF Fund Management's Oruka Therapeutics position peaked at $113K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.